Maiden Pharma responsible for deaths of 70 children from acute kidney injury: Gambian Parliamentary committee
"All the cases of AKI are linked to the consumption of contaminated medical products...manufactured by Maiden Pharmaceuticals," the committee's chairperson Amadou Camara said in a statement to parliament.
Advertisement
Dakar: A parliamentary committee in Gambia said that India-based drug maker Maiden Pharmaceuticals Ltd was responsible for the deaths of at least 70 children from acute kidney injury and called on the government to pursue legal action.
Maiden's managing director, Naresh Kumar Goyal, did not immediately respond to calls and messages from Reuters on Tuesday.
The World Health Organization in October said four medicinal syrups made by Maiden and imported by a local wholesaler were likely linked to the deaths, which have shocked the West African country since July. The drugs were pulled from the shelves and Maiden's production licence in India was suspended.
After its investigation, Gambia's select committee on health reached a similar conclusion.
"All the cases of AKI are linked to the consumption of contaminated medical products...manufactured by Maiden Pharmaceuticals," the committee's chairperson Amadou Camara said in a statement to parliament.
Goyal on Friday told Reuters that his company had done no wrong.
The WHO in October said that lab analysis confirmed "unacceptable" amounts of diethylene glycol and ethylene glycol in the medicines made by Maiden, which can be toxic and lead to acute kidney injury.
Earlier this month India told the WHO that tests of samples from the same batches of syrups that were sent to Gambia were compliant with government specifications.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.